Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC
NSCLC is the leading cause of cancer deaths globally, with EGFR mutations being a common feature in these cancers.
Source: news-medical.net
Stay updated with breaking news from Bang Yu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NSCLC is the leading cause of cancer deaths globally, with EGFR mutations being a common feature in these cancers.